Literature DB >> 6430234

Modulation of platelet-activating factor (PAF) synthesis and release from human polymorphonuclear leukocytes (PMN): role of extracellular Ca2+.

J C Ludwig, L M McManus, P O Clark, D J Hanahan, R N Pinckard.   

Abstract

Extracellular Ca2+ regulated the synthesis and release of platelet-activating factor (PAF) from human polymorphonuclear leukocytes (PMN) stimulated with N'-formyl-methionyl-leucyl-phenylalanine (FMLP) in the presence of cytochalasin B. Maximum PAF synthesis and release required the presence of 0.14 mM Ca2+ whereas 1.4 mM Ca2+ was necessary for maximum lysosomal enzyme secretion. The synthesis of PAF occurred within 2.5 min after PMN stimulation in the presence of 1.4 mM Ca2+; however, PAF release did not occur until 5 min after stimulation. Peak PAF release occurred by 7.5 min but accounted for only 30-40% of the total amount of PAF synthesized, the remainder being retained on or within the PMN. Stimulation of PMN in the presence of 0.01 M EDTA or EGTA decreased PAF synthesis and release by greater than 95%. In the absence of extracellular Ca2+, stimulated PMN synthesized PAF in amounts that were 10-30% of maximum, but there was no release of the newly synthesized PAF. At Ca2+ concentrations greater than 0.01 mM, there was a dose-dependent (up to 0.14 mM) increase in PAF synthesis that was associated with the initiation and concomitant increase in the amount of PAF released. These data suggest the presence of a PAF synthesis-release coupling mechanism in which the extracellular Ca2+-dependent release of PAF stimulates additional PAF synthesis.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6430234     DOI: 10.1016/0003-9861(84)90525-3

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


  9 in total

1.  Effect of inhaled formyl-methionyl-leucyl-phenylalanine on airway function.

Authors:  N Berend; M J Peters; C L Armour; J L Black; H E Ward
Journal:  Thorax       Date:  1988-01       Impact factor: 9.139

2.  1-Acyl-2-acetyl-sn-glycero-3-phosphocholine from stimulated human polymorphonuclear leukocytes.

Authors:  K Satouchi; M Oda; K Saito
Journal:  Lipids       Date:  1987-04       Impact factor: 1.880

3.  1-O-alkyl-2-acetyl-sn-glycerol: a platelet-activating factor metabolite with biological activity in vascular smooth muscle cells.

Authors:  L L Stoll; P H Figard; N R Yerram; M A Yorek; A A Spector
Journal:  Cell Regul       Date:  1989-11

4.  A sensitive and specific radioimmunoassay for platelet-activating factor.

Authors:  C Wang; H H Tai
Journal:  Lipids       Date:  1992-03       Impact factor: 1.880

5.  Production of platelet-activating factor is a component of the angiotensin II-protein kinase C activation pathway in bovine adrenocortical cells.

Authors:  J M Pelosin; M Keramidas; E M Chambaz
Journal:  Biochem J       Date:  1991-08-15       Impact factor: 3.857

6.  Transient activation of 1-O-alkyl-sn-glycero-3-phosphocholine: acetyl-CoA acetyltransferase during the incubation of macrophages.

Authors:  T Sugiura; T Fukuda; N N Cheng; K Waku
Journal:  Lipids       Date:  1991-11       Impact factor: 1.880

7.  Platelet-activating factor: mediator of the third pathway of platelet aggregation? A study in three patients with deficient platelet-activating factor synthesis.

Authors:  A Sturk; M C Schaap; J W ten Cate; H S Heymans; R B Schutgens; H Przyrembel; P Borst
Journal:  J Clin Invest       Date:  1987-02       Impact factor: 14.808

8.  Dynamics of platelet-activating-factor release and uptake in a human neutrophil suspension.

Authors:  M Cluzel; C A Rohde; D W MacGlashan; B J Undem; F H Chilton
Journal:  Biochem J       Date:  1991-09-01       Impact factor: 3.857

9.  Calcium channel blockade inhibits platelet activating factor production by human umbilical vein endothelial cells.

Authors:  J P Tolins; A Melemed; D Sulciner; K S Gustafson; G M Vercellotti
Journal:  Lipids       Date:  1991-12       Impact factor: 1.880

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.